Search for: "MAJOR PHARMACEUTICALS" Results 381 - 400 of 4,371
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 May 2022, 9:02 pm by Penn Program on Regulation
Listeners can subscribe to the Race and Regulation podcast series via Apple Podcasts, Google Podcasts, Spotify, and other major streaming services.The post Connecting Race and Regulation first appeared on The Regulatory Review. [read post]
30 May 2022, 5:40 am by Kevin LaCroix
  Background Cardinal Health is one of the largest pharmaceutical products distributors in the United States. [read post]
25 May 2022, 5:16 am by Michael Ehline
In the medicinal field, mistakes made during operations and the treatment of illnesses are also major factors that lead to wrongful death. [read post]
24 May 2022, 5:10 pm by Michael Ehline
In the medicinal field, mistakes made during operations and the treatment of illnesses are also major factors that lead to wrongful death. [read post]
24 May 2022, 5:00 pm by Michael Ehline
In the medicinal field, mistakes made during operations and the treatment of illnesses are also major factors that lead to wrongful death. [read post]
24 May 2022, 4:23 pm by Bill Marler
What we know: There have been four sick with two dead from Cronobacter sakazakii linked to Abbott’s manufacturing plant. [read post]
24 May 2022, 5:43 am by Rob Robinson
It recognizes the importance of key structural trends with major implications for the EU’s digital ambitions to 2030 and beyond. [read post]
24 May 2022, 5:43 am by Rob Robinson
It recognizes the importance of key structural trends with major implications for the EU’s digital ambitions to 2030 and beyond. [read post]
23 May 2022, 4:05 am by Joseph Parise
If the strong version of the EMH is true, why do pharmaceutical stock prices spike upon FDA approval of a new drug. [read post]
20 May 2022, 11:01 am by Gus Hurwitz
Will the FTC risk major litigation questions with a “go big or go home” attitude, or will it take a more incrementalist approach to boiling the frog? [read post]
20 May 2022, 9:00 am by Mridu Katoch
The rapidly changing competitive landscape suggests that some of the traditional innovators are perhaps no longer major players while others have risen to the challenge. [read post]
13 May 2022, 11:28 am by Gus Hurwitz
” But as with any discussion of the “major” questions doctrine, the implicit question is when a question is “major. [read post]
4 May 2022, 8:01 am by Andrew Hayashi
Although many U.S. businesses have curtailed operations in Russia, major pharmaceutical companies continue to operate there. [read post]
3 May 2022, 1:55 am by Kevin Kaufman
Key Findings Federal policymakers are debating a legislative package focused on boosting U.S. competitiveness vis-a-vis China; however, it currently contains little to no improvements to the U.S. tax code. [read post]
1 May 2022, 6:57 am by Dan Currell
  Many fail to launch at all, and in our experience, the vast majority fail to achieve their potential. [read post]
30 Apr 2022, 7:01 pm by Katherine Pompilio
They spoke about the judge’s approach to statutory interpretation, the role of the major questions doctrine, whether her views are likely to survive appeal and how the entire endeavor is likely to impact ongoing efforts to combat the coronavirus pandemic: Paul Rosenzweig argued that the pharmaceutical industry’s use of artificial intelligence makes possible not only the creation of new drugs but also the development of catastrophic new biological and chemical weapons. [read post]
27 Apr 2022, 11:00 am by Katherine Pompilio
  The majority of Americans have been infected with the coronavirus, according to the Washington Post. [read post]
26 Apr 2022, 3:48 pm by luiza
  Generic drug maker Hikma Pharmaceuticals has won U.S. antitrust approval to buy Custopharm, Inc on condition that it divest an injectable steroid, the U.S. [read post]
19 Apr 2022, 8:05 am by Mridu Katoch
One justification for this could be that pharmaceutical companies may not have as many patents as companies like Apple, Google, or Canon. [read post]